Alaska Permanent Fund Corporation — 2023 Investments
1 investments dated 2023 · listed companies and verified rows first · show all
Thomas H. Lee Partnersthl.cominFeb 2023
Celerion provides clinical pharmacology and bioanalytical services to support pharmaceutical and biotechnology companies in early-phase drug development and regulatory submissions.
BiotechHealthtechLincoln, US
Susan Thornton(Founder and Chief Executive Officer)
Co-investorsBCIKensington Capital Partners Limited
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.